The data illustrated that RBM14 expression was closely associated with TP53 mutation status and individual cancer stage, whereas there was no relation between RBM14 expression and patient’s gender, patient’s age, patient’s smoking habits, and nodal metastasis status (Fig. S1). This evidence concerns the gene RBM14 and cancer.